Merck & Co., Inc.·4

Jan 25, 4:52 PM ET

DeLuca Richard R. 4

4 · Merck & Co., Inc. · Filed Jan 25, 2023

Insider Transaction Report

Form 4
Period: 2023-01-23
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Transactions
  • Award

    Common Stock

    2023-01-23$109.88/sh+15,628$1,717,205153,500.379 total
Holdings
  • Common Stock - 401(k) Plan

    (indirect: By 401(k))
    1,198.05
Footnotes (3)
  • [F1]Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/20. Performance shares were paid out at 110 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2022.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.
  • [F3]Includes shares acquired and dividends earned through January 9, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT